Kidney transplantation and menstrual changes

Kim, J.-H; Chun, Calvin; Kang, Chong Myung; Kwak, J. Y.

doi:10.1016/s0041-1345(98)00928-2

Cited by 35 publications

(31 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One explanation may be the return of menses in age-appropriate females after successful transplantation, which may in turn potentiate anemia through iron deficiency. Studies of reproductive function following kidney transplantation have demonstrated that menstruation generally resumes in ageappropriate females within the first 6 months after transplantation (28,29), and may be seen as early as 6 weeks after transplantation (30). Furthermore, iron deficiency has been reported to be common in both male and female kidney transplant recipients.…”

Section: Discussionmentioning

confidence: 99%

Anemia: A Continuing Problem Following Kidney Transplantation

Mix¹,

Kazmi²,

Khan³

et al. 2003

American Journal of Transplantation

156

115

View full text Add to dashboard Cite

Cardiovascular disease is a leading cause of death among kidney transplant recipients. Anemia, a risk factor for cardiovascular complications among patients with chronic kidney disease, has not been well characterized in kidney transplant recipients. We performed a retrospective cohort study of the prevalence of and factors associated with anemia among 240 patients who underwent kidney transplantation at our institution. The mean hematocrit (Hct) rose from 33% at 1 month after transplantation to 40% at 12 months after transplantation. The proportion of patients with Hct < 36% was 76% at transplantation and 21% and 36%, 1 year and 4 years after transplantation, respectively. Six months after transplantation, women had higher likelihood (OR = = 3.61) of Hct < 36%, while higher Hct at 3 months (OR = = 0.67 for 1% higher Hct) and diabetes (OR = = 0.14) were associated with a lower likelihood of Hct < 36%. Similar associations were seen 12 months after transplantation. Even among patients with Hct < 30%, only 36% had iron studies, 46% received iron supplementation and 40% received recombinant human erythropoietin. Awareness of factors associated with a lower Hct may prompt better anemia screening and management, potentially improving cardiovascular outcomes among kidney transplant recipients.

show abstract

Section: Discussionmentioning

confidence: 99%

Anemia: A Continuing Problem Following Kidney Transplantation

Mix¹,

Kazmi²,

Khan³

et al. 2003

American Journal of Transplantation

156

115

View full text Add to dashboard Cite

show abstract

“…225,[249][250][251][252][253] However, because these patients may underestimate their own fertility and because subspecialty physicians underestimate sexual activity and contraceptive needs in patients with chronic disease, it is imperative that primary care physicians assess these issues. [254][255][256] For transplant recipients who choose not to remain abstinent, a highly effective method is indicated. Patients who have established normal organ function and are stable at least 6 to 8 months after transplantation can use any of the currently available hormonal contraceptives, provided they do not have other contraindications to the estrogen component.…”

Section: Adolescent Recipients Of Solid Organ Transplantationmentioning

confidence: 99%

Contraception for Adolescents

Ott

Sucato²

2014

Pediatrics

242

133

View full text Add to dashboard Cite

A working knowledge of contraception will assist the pediatrician in both sexual health promotion as well as treatment of common adolescent gynecologic problems. Best practices in adolescent anticipatory guidance and screening include a sexual health history, screening for pregnancy and sexually transmitted infections, counseling, and if indicated, providing access to contraceptives. Pediatricians’ long-term relationships with adolescents and families allow them to help promote healthy sexual decision-making, including abstinence and contraceptive use. Additionally, medical indications for contraception, such as acne, dysmenorrhea, and heavy menstrual bleeding, are frequently uncovered during adolescent visits. This technical report provides an evidence base for the accompanying policy statement and addresses key aspects of adolescent contraceptive use, including the following: (1) sexual history taking, confidentiality, and counseling; (2) adolescent data on the use and side effects of newer contraceptive methods; (3) new data on older contraceptive methods; and (4) evidence supporting the use of contraceptives in adolescent patients with complex medical conditions.

show abstract

“…Reproductive recovery depends ultimately on the improvement of ovarian function and normalization of the HPO axis. Following successful graft and a stable serum creatinine (1.4 mg/dL), most patients resume normal menses within the first year of OT (average of 5e7 months) [15,22]. Premature ovarian insufficiency (POI) is rare in CRF patients and varies between 4% and 20% in renal OTr [20], possibly related to the underlying renal aetiology and use of gonadotoxic therapy.…”

Section: Renal Transplantation Femalementioning

confidence: 99%